Figure 3.

5-Year Mortality in Patients With Cardiac Amyloidosis by Time Period

The mortality among patients with cardiac amyloidosis (CA)was described for each 5-year period of the study with the use of cumulative incidence functions. The mortality decreased significantly between the first and last 5-year periods. The improved survival might be explained by increased earlier detection of less severe cases of CA, a greater incidence of new cases of transthyretin amyloidosis vs amyloid light chain amyloidosis, and progress in the treatment of amyloid light chain amyloidosis.